Cannabis for the treatment of amyotrophic lateral sclerosis: What is the patients’ view?Clémence Lacroix, Olivier Blin, Gaëlle Bruneteau et al.|Revue Neurologique|2023Cited by 32
What Do We Know About Medical Cannabis in Neurological Disorders and What Are the Next Steps?Clémence Lacroix, Olivier Blin, Joëlle Micallef et al.|Frontiers in Pharmacology|2022Cited by 16
Cannabidiol and pharmacokinetics drug-drug interactions: Pharmacological toolboxClémence Lacroix, Olivier Blin, Joëlle Micallef et al.|Therapies|2023Cited by 8
Antibiotic-induced neurological adverse drug reactionsClémence Lacroix, Joëlle Micallef, Thomas Soeiro et al.|Therapies|2023Cited by 6